{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:34Z","timestamp":1786985614291,"version":"build-2736575974"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.canlet.2023.216466","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T07:36:46Z","timestamp":1699429006000},"page":"216466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses"],"prefix":"10.1016","volume":"581","author":[{"given":"Xing","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3820-1428","authenticated-orcid":false,"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2401-5349","authenticated-orcid":false,"given":"Quan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2018","key":"10.1016\/j.canlet.2023.216466_bib1","first-page":"7","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2023.216466_bib2","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/annonc\/mds591","article-title":"Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I\/II study and pharmacokinetic analysis","volume":"24","author":"Tawbi","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2023.216466_bib3","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2023.216466_bib4","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(17)31601-X","article-title":"Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)","volume":"390","author":"Schachter","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2023.216466_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2023.216466_bib6","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S1470-2045(19)30388-2","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study","volume":"20","author":"Robert","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2023.216466_bib7","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/annonc\/mdw217","article-title":"Immune escape to PD-L1\/PD-1 blockade: seven steps to success (or failure)","volume":"27","author":"Kim","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2023.216466_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1359-6101(01)00038-7","article-title":"The roles of IFN gamma in protection against tumor development and cancer immunoediting","volume":"13","author":"Ikeda","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.canlet.2023.216466_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143296","article-title":"Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response","volume":"131","author":"von Locquenghien","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2023.216466_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.immuni.2018.01.010","article-title":"NKp46 receptor-mediated interferon-\u03b3 production by natural killer cells increases fibronectin 1 to alter tumor architecture and control metastasis","volume":"48","author":"Glasner","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216466_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-\u03b3 pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2023.216466_bib12","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2023.216466_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2023.216466_bib14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2023.216466_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ccell.2020.11.015","article-title":"Conserved interferon-\u03b3 signaling drives clinical response to immune checkpoint blockade therapy in melanoma","volume":"39","author":"Grasso","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2023.216466_bib16","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jnci\/djt184","article-title":"MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells, JNCI","volume":"105","author":"Leone","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2023.216466_bib17","article-title":"PSMB9 codon 60 polymorphisms have no impact on the activity of the immunoproteasome catalytic subunit B1i expressed in multiple types of solid cancer","volume":"8","author":"Park","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2023.216466_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14205007","article-title":"The expression of the immunoproteasome subunit PSMB9 is related to distinct molecular subtypes of uterine leiomyosarcoma","volume":"14","author":"Maia Falc\u00e3o","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2023.216466_bib19","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41467-020-14639-9","article-title":"Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma","volume":"11","author":"Kalaora","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216466_bib20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/1074-7613(94)90043-4","article-title":"Altered peptidase and viral-specific T cell response in LMP2 mutant mice","volume":"1","author":"Van Kaer","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216466_bib21","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41588-020-00726-6","article-title":"Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity","volume":"52","author":"Kinker","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2023.216466_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41576-020-00292-x","article-title":"Deciphering cell\u2013cell interactions and communication from gene expression","volume":"22","author":"Armingol","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2023.216466_bib23","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","article-title":"A scalable SCENIC workflow for single-cell gene regulatory network analysis","volume":"15","author":"Van de Sande","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2023.216466_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2023.216466_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1288329","article-title":"The immune molecular landscape of the B7 and TNFR immunoregulatory ligand-receptor families in head and neck cancer: a comprehensive overview and the immunotherapeutic implications","volume":"6","author":"Chen","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2023.216466_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1964189","article-title":"Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy","volume":"10","author":"Sun","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2023.216466_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12920-015-0147-4","article-title":"DNA methylation subgroups in melanoma are associated with proliferative and immunological processes","volume":"8","author":"Lauss","year":"2015","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.canlet.2023.216466_bib28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2023.216466_bib29","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load","volume":"10","author":"Jung","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216466_bib30","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/jid.2015.61","article-title":"Genome-wide DNA methylation analysis in melanoma reveals the importance of CpG methylation in MITF regulation","volume":"135","author":"Lauss","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2023.216466_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","article-title":"Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma","volume":"22","author":"Sturm","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2023.216466_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00401-018-1810-6","article-title":"The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033","volume":"135","author":"Bady","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.canlet.2023.216466_bib33","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s12276-020-00493-8","article-title":"Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer","volume":"52","author":"Cho","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.canlet.2023.216466_bib34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41598-019-57218-9","article-title":"Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer","volume":"10","author":"Hwang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2023.216466_bib35","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","article-title":"Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma","volume":"24","author":"Auslander","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2023.216466_bib36","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41416-021-01488-6","article-title":"Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience","volume":"125","author":"Rose","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216466_bib37","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A cancer cell Program promotes T cell exclusion and resistance to checkpoint blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2023.216466_bib38","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2023.216466_bib39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.canlet.2023.216466_bib40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","article-title":"ChAMP: 450k chip analysis methylation pipeline","volume":"30","author":"Morris","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2023.216466_bib41","series-title":"Impute: Impute","author":"Hastie","year":"2023"},{"key":"10.1016\/j.canlet.2023.216466_bib42","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2023.216466_bib43","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2023.216466_bib44","series-title":"GSEABase: Gene Set Enrichment Data Structures and Methods","author":"Morgan M","year":"2023"},{"key":"10.1016\/j.canlet.2023.216466_bib45","series-title":"enrichplot: Visualization of Functional Enrichment Result","author":"Yu","year":"2023"},{"key":"10.1016\/j.canlet.2023.216466_bib46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2164-14-293","article-title":"A data-driven approach to preprocessing Illumina 450K methylation array data","volume":"14","author":"Pidsley","year":"2013","journal-title":"BMC Genom."},{"key":"10.1016\/j.canlet.2023.216466_bib47","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1038\/s41467-018-05570-1","article-title":"Pan-cancer deconvolution of tumour composition using DNA methylation","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216466_bib48","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2023.216466_bib49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2023.216466_bib50","first-page":"28","article-title":"Package \u2018survival\u2019","volume":"128","author":"Therneau","year":"2015","journal-title":"R Top Doc"},{"key":"10.1016\/j.canlet.2023.216466_bib51","series-title":"randomForestSRC: Variable Importance (VIMP) with Subsampling Inference Vignette","author":"Ishwaran","year":"2021"},{"key":"10.1016\/j.canlet.2023.216466_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.canlet.2023.216466_bib53","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time\u2010dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat. Med."},{"key":"10.1016\/j.canlet.2023.216466_bib54","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216466_bib55","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2023.216466_bib56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13059-015-0844-5","article-title":"MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data","volume":"16","author":"Finak","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2023.216466_bib57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","article-title":"NicheNet: modeling intercellular communication by linking ligands to target genes","volume":"17","author":"Browaeys","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.canlet.2023.216466_bib58","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.canlet.2023.216466_bib59","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.21105\/joss.03167","article-title":"Visualizations with statistical details: the 'ggstatsplot' approach","volume":"6","author":"Patil","year":"2021","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.canlet.2023.216466_bib60","first-page":"1","article-title":"Drawing survival curves using \u2018ggplot2\u2019","author":"Kassambara","year":"2017","journal-title":"R package version 0.3"},{"key":"10.1016\/j.canlet.2023.216466_bib61","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2009"},{"key":"10.1016\/j.canlet.2023.216466_bib62","series-title":"Pheatmap: Pretty Heatmaps. R Package","author":"Kolde","year":"2019"},{"key":"10.1016\/j.canlet.2023.216466_bib63","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13148-018-0534-8","article-title":"Increased epigenetic age in normal breast tissue from luminal breast cancer patients","volume":"10","author":"Hofstatter","year":"2018","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.canlet.2023.216466_bib64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40478-022-01344-5","article-title":"DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome-including in elderly patients","volume":"10","author":"Bady","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.canlet.2023.216466_bib65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13148-019-0801-3","article-title":"Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk","volume":"12","author":"Wang","year":"2020","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.canlet.2023.216466_bib66","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","article-title":"DNA methylation age of human tissues and cell types","volume":"14","author":"Horvath","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2023.216466_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215937","article-title":"Fueling immune checkpoint blockade with oncolytic viruses: current paradigms and challenges ahead","volume":"550","author":"Li","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216466_bib69","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2023.216466_bib70","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1158\/0008-5472.CAN-12-1187","article-title":"PD-1 blockade enhances T-cell migration to tumors by elevating IFN-\u03b3 inducible chemokines","volume":"72","author":"Peng","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216466_bib71","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1196\/annals.1310.015","article-title":"Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial","volume":"1020","author":"Izmirlian","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.canlet.2023.216466_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215896","article-title":"Molecular imaging of immune checkpoints in oncology: current and future applications","volume":"548","author":"Ge","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216466_bib73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40425-016-0111-7","article-title":"Mismatch in epitope specificities between IFN\u03b3 inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma","volume":"4","author":"Woods","year":"2016","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2023.216466_bib74","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-065X.1998.tb01195.x","article-title":"The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28","volume":"163","author":"Tanaka","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.canlet.2023.216466_bib75","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0952-7915(99)80014-4","article-title":"Antigen presentation by MHC class I and its regulation by interferon gamma","volume":"11","author":"Fr\u00fch","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.canlet.2023.216466_bib76","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2021.12.008","article-title":"Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing","volume":"527","author":"Hern\u00e1ndez Mart\u00ednez","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216466_bib77","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41467-020-14987-6","article-title":"Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours","volume":"11","author":"Brenner","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216466_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000974","article-title":"Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma","volume":"8","author":"Thompson","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2023.216466_bib79","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-018-0812-9","article-title":"Tissue-resident memory CD8(+) T cells promote melanoma-immune equilibrium in skin","volume":"565","author":"Park","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2023.216466_bib80","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1038\/s41467-023-40107-1","article-title":"IKK2\/NFkB signaling controls lung resident CD8(+) T cell memory during influenza infection","volume":"14","author":"Pritzl","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216466_bib81","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1101\/gad.813200","article-title":"The Rb\/E2F pathway: expanding roles and emerging paradigms","volume":"14","author":"Harbour","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2023.216466_bib82","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1128\/MCB.21.24.8547-8564.2001","article-title":"E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis","volume":"21","author":"Zhu","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2023.216466_bib83","doi-asserted-by":"crossref","first-page":"9213","DOI":"10.1073\/pnas.91.20.9213","article-title":"Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7","volume":"91","author":"Gaczynska","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2023.216466_bib84","first-page":"2691","article-title":"Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models, Cancer Immunology","volume":"71","author":"\u017dilionyt\u0117","year":"2022","journal-title":"Immunotherapy"},{"key":"10.1016\/j.canlet.2023.216466_bib85","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1073\/pnas.1602069113","article-title":"NLRC5\/MHC class I transactivator is a target for immune evasion in cancer","volume":"113","author":"Yoshihama","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2023.216466_bib86","first-page":"641","article-title":"Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6","volume":"2","author":"Maeurer","year":"1996","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216466_bib87","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1158\/2326-6066.CIR-20-0492","article-title":"Pro- and antitumorigenic capacity of immunoproteasomes in shaping the tumor microenvironment","volume":"9","author":"Leister","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2023.216466_bib88","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41556-020-0547-3","article-title":"Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma","volume":"22","author":"Wouters","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2023.216466_bib89","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41467-022-29541-9","article-title":"STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming","volume":"13","author":"Chu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216466_bib90","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.immunol.24.021605.090700","article-title":"Natural killer cell developmental pathways: a question of balance","volume":"24","author":"Di Santo","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2023.216466_bib91","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.ymthe.2018.06.016","article-title":"Combination of asiatic acid and naringenin modulates NK cell anti-cancer immunity by rebalancing Smad3\/Smad7 signaling","volume":"26","author":"Lian","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2023.216466_bib92","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/s41591-018-0217-1","article-title":"Translational control of tumor immune escape via the eIF4F\u2013STAT1\u2013PD-L1 axis in melanoma","volume":"24","author":"Cerezo","year":"2018","journal-title":"Nat. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523004172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523004172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:11:53Z","timestamp":1759594313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523004172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":91,"alternative-id":["S0304383523004172"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216466","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"216466"}}